Fasciolosis
fasciolosis latin

Studies carried out in recent years have shown human fasciolosis to be an important public health problem.

The signs were similar to well known fasciolosis in sheep.

A number of drugs have been used in control fasciolosis in animals.

A global analysis shows that the expected correlation between animal and human fasciolosis only appears at a basic level.

In Australia, human fasciolosis is very rare (only 12 cases documented).

These Andean countries are considered to be the area with the highest prevalence of human fasciolosis in the world.

The course of fasciolosis in humans has 4 main phases:

In Africa, human cases of fasciolosis, except in northern parts, have not been frequently reported.

In eastern Asia, human fasciolosis appears to be sporadic.

The disease caused by the fluke is called fascioliasis (also known as fasciolosis).

Several papers referred to human fasciolosis in Turkey.

Recently, serological survey of human fasciolosis was performed in some parts of Turkey.

Resistance to fasciolosis was also documented in rats.

There are case reports of nitazoxanide being successfully used in human fasciolosis treatment in Mexico.

Various species in Lymnaeidae are intermediate hosts of fasciolosis.

Countries where fasciolosis in livestock was repeatedly reported:

Triclabendazole is used in control of fasciolosis of livestock in many countries.

High prevalences in humans are not necessarily found in areas where fasciolosis is a great veterinary problem.

The consumption of dandelion leaves has also been implicated in occurrences of fasciolosis.

Human and animal fasciolosis occurs worldwide.

Calves are susceptible to disease but in excess of 1000 metacercariae are usually required to cause clinical fasciolosis.

They causes the disease fasciolosis.

In other European countries, fasciolosis is sporadic and the occurrence of the disease is usually combined with travelling to endemic areas.

In blood, anemia, hypoalbuminemia, and eosinophilia may be observed in all types of fasciolosis.

Chronic Fasciolosis: infectious dose is 200-800 ingested metacercariae.

Studies carried out in recent years have shown human fasciolosis to be an important public health problem.

The signs were similar to well known fasciolosis in sheep.

A number of drugs have been used in control fasciolosis in animals.

A global analysis shows that the expected correlation between animal and human fasciolosis only appears at a basic level.

In Australia, human fasciolosis is very rare (only 12 cases documented).

These Andean countries are considered to be the area with the highest prevalence of human fasciolosis in the world.

The course of fasciolosis in humans has 4 main phases:

In Africa, human cases of fasciolosis, except in northern parts, have not been frequently reported.

In eastern Asia, human fasciolosis appears to be sporadic.

The disease caused by the fluke is called fascioliasis (also known as fasciolosis).

Several papers referred to human fasciolosis in Turkey.

Recently, serological survey of human fasciolosis was performed in some parts of Turkey.

Resistance to fasciolosis was also documented in rats.

There are case reports of nitazoxanide being successfully used in human fasciolosis treatment in Mexico.

Various species in Lymnaeidae are intermediate hosts of fasciolosis.

Countries where fasciolosis in livestock was repeatedly reported:

Triclabendazole is used in control of fasciolosis of livestock in many countries.

High prevalences in humans are not necessarily found in areas where fasciolosis is a great veterinary problem.

The consumption of dandelion leaves has also been implicated in occurrences of fasciolosis.

Human and animal fasciolosis occurs worldwide.

Calves are susceptible to disease but in excess of 1000 metacercariae are usually required to cause clinical fasciolosis.

They causes the disease fasciolosis.

In other European countries, fasciolosis is sporadic and the occurrence of the disease is usually combined with travelling to endemic areas.

In blood, anemia, hypoalbuminemia, and eosinophilia may be observed in all types of fasciolosis.

Chronic Fasciolosis: infectious dose is 200-800 ingested metacercariae.